19-1218436-A-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_000455.5(STK11):c.310A>T(p.Arg104Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.310A>T | p.Arg104Trp | missense_variant | Exon 2 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.310A>T | p.Arg104Trp | missense_variant | Exon 2 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1577A>T | non_coding_transcript_exon_variant | Exon 3 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.310A>T | p.Arg104Trp | missense_variant | Exon 2 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.310A>T | p.Arg104Trp | missense_variant | Exon 2 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748 | c.-63A>T | 5_prime_UTR_variant | Exon 4 of 12 | 3 | ENSP00000477641.2 | ||||
STK11 | ENST00000593219.5 | n.*135A>T | non_coding_transcript_exon_variant | Exon 3 of 4 | 3 | ENSP00000466610.1 | ||||
STK11 | ENST00000593219.5 | n.*135A>T | 3_prime_UTR_variant | Exon 3 of 4 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461296Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726898
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74366
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:1Benign:1
- -
- -
not specified Uncertain:1
Variant summary: STK11 c.310A>T (p.Arg104Trp) results in a non-conservative amino acid change located in the Protein kinase domain (IPR000719) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249174 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.310A>T in individuals affected with Peutz-Jeghers Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 142871). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Peutz-Jeghers syndrome;C2931038:Familial pancreatic carcinoma Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R104W variant (also known as c.310A>T), located in coding exon 2 of the STK11 gene, results from an A to T substitution at nucleotide position 310. The arginine at codon 104 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was reported in 1/60,466 breast cancer cases and in 0/53,461 controls (Dorling et al. N Engl J Med. 2021 02;384:428-439). This variant has been detected in multiple individuals with no reported features of Peutz-Jeghers syndrome (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. -
Melanoma, cutaneous malignant, susceptibility to, 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at